Neuronal nuclear organization is controlled by cyclin-dependent kinase 5 phosphorylation of Ras guanine nucleotide releasing factor-1

NeuroSignals

Volumn 15, Issue 4, 2007, Pages 157-173

  Kesavapany, Sashi ^a   Pareek, Tej Kumar ^b   Zheng, Ya Li ^a   Amin, Niranjana ^a   Gutkind, J Silvio ^c   Ma, Wu ^d   Kulkarni, Ashok B ^b   Grant, Philip ^a   Pant, Harish C ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^d NAVAL RESEARCH LABORATORY   (United States)

Author keywords

Cdk5; Nuclear organization; p35; Phosphorylation; Ras; RasGRF1

Indexed keywords

CALPAIN; CYCLIN DEPENDENT KINASE 5; GUANINE NUCLEOTIDE EXCHANGE FACTOR; MUTANT PROTEIN; PROTEIN P35; RAS PROTEIN; SERINE DERIVATIVE;

ANIMAL CELL; ARTICLE; BINDING SITE; BRAIN CELL; CELL NUCLEUS; CHROMATIN CONDENSATION; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; KNOCKOUT MOUSE; MITOSIS; MOUSE; NERVE CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN STRUCTURE; STEADY STATE; WILD TYPE;

ANIMALS; BINDING SITES; CALPAIN; CELL DEATH; CELL NUCLEUS; CERCOPITHECUS AETHIOPS; CEREBRAL CORTEX; CHO CELLS; COS CELLS; CRICETINAE; CRICETULUS; CYCLIN-DEPENDENT KINASE 5; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION; MICE; MICE, KNOCKOUT; NEURONS; PHOSPHORYLATION; RAS-GRF1; RATS; SERINE; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 34250184630     PISSN: 1424862X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095130     Document Type: Article

References (50)

1. Tsai LH, Delalle I, Caviness VS Jr, Chae T, Harlow E: p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 1994;371:419-423.
2. Humbert S, Lanier LM, Tsai LH: Synaptic localization of p39, a neuronal activator of cdk5. Neuroreport 2000;11:2213-2216.
3. Nikolic M, Dudek H, Kwon YT, Ramos YF, Tsai LH: The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev 1996;10:816-825.
4. Ohshima T, Ward JM, Huh CG, et al: Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci USA 1996;93:11173-11178.
5. Kesavapany S, Lau KF, McLoughlin DM, et al: p35/cdk5 binds and phosphorylates beta-catenin and regulates beta-catenin/presenilin-1 interaction. Eur J Neurosci 2001;13:241-247.
6. Kwon YT, Gupta A, Zhou Y, Nikolic M, Tsai LH: Regulation of N-cadherin-mediated adhesion by the p35-Cdk5 kinase. Curr Biol 2000;10:363-372.
7. Shuang R, Zhang L, Fletcher A, Groblewski GE, Pevsner J, Stuenkel EL: Regulation of Munc-18/syntaxin 1A interaction by cyclindependent kinase 5 in nerve endings. J Biol Chem 1998;273:4957-4966.
8. Rosales JL, Nodwell MJ, Johnston RN, Lee KY: Cdk5/p25(nck5a) interaction with synaptic proteins in bovine brain. J Cell Biochem 2000;78:151-159.
9. Fletcher AI, Shuang R, Giovannucci DR, Zhang L, Bittner MA, Stuenkel EL: Regulation of exocytosis by cyclin-dependent kinase 5 via phosphorylation of Munc18. J Biol Chem 1999;274:4027-4035.
10. Matsubara M, Kusubata M, Ishiguro K, Uchida T, Titani K, Taniguchi H: Site-specific phosphorylation of synapsin I by mitogen-activated protein kinase and Cdk5 and its effects on physiological functions. J Biol Chem 1996;271:21108-21113.
11. Tomizawa K, Cai XH, Moriwaki A, Matsushita M, Matsui H: Involvement of cyclin-dependent kinase 5/p35(nck5a) in the synaptic reorganization of rat hippocampus during kindling progression. Jpn J Physiol 2000;50:525-32.
12. Tan TC, Valova VA, Malladi CS, et al: Cdk5 is essential for synaptic vesicle endocytosis. Nat Cell Biol 2003;5:701-710.
13. Bibb JA, Snyder GL, Nishi A, et al: Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature 1999;402:669-671.
14. Takahashi S, Ohshima T, Cho A, et al: Increased activity of cyclin-dependent kinase 5 leads to attenuation of cocaine-mediated dopamine signaling. Proc Natl Acad Sci USA 2005;102:1737-1742.
15. Fu AK, Fu WY, Cheung J, et al: Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction. Nat Neurosci 2001;4:374-381.
16. Bibb JA, Chen J, Taylor JR, et al: Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 2001;410:376-380.
17. Fu AK, Ip FC, Fu WY, et al: Aberrant motor axon projection, acetylcholine receptor clustering, and neurotransmission in cyclin-dependent kinase 5 null mice. Proc Natl Acad Sci USA 2005;102:15224-15229.
18. Sharma P, Veeranna, Sharma M, et al: Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway. J Biol Chem 2002;277:528-534.
19. Zhen X, Goswami S, Abdali SA, Gil M, Bakshi K, Friedman E: Regulation of cdk5 and CaMK II by PI-linked dopamine receptor in rat brain. Mol Pharmacol 2004.
20. Li BS, Zhang L, Takahashi S, et al: Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J 2002;21:324-333.
21. Kesavapany S, Amin N, Zheng YL, et al: p35/cyclin-dependent kinase 5 phosphorylation of ras guanine nucleotide releasing factor 2 (RasGRF2) mediates Rac-dependent extra-cellular signal-regulated kinase 1/2 activity, altering RasGRF2 and microtubule-associated protein 1b distribution in neurons. J Neurosci 2004;24:4421-4431.
22. Patzke H, Tsai LH: Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29. J Biol Chem 2002;277:8054-8060.
23. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH: Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 2000;405:360-364.
24. Zheng YL, Kesavapany S, Gravell M, et al: A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons. EMBO J 2005;24:209-220.
25. Kesavapany S, Lau KF, Ackerley S, et al: Identification of a novel, membrane-associated neuronal kinase, cyclin-dependent kinase 5/p35-regulated kinase. J Neurosci 2003;23:4975-4983.
26. Kesavapany S, Banner SJ, Lau KF, et al: Expression of the Fe65 adapter protein in adult and developing mouse brain. Neuroscience 2002;115:951-960.
27. Amin ND, Albers W, Pant HC: Cyclin-dependent kinase 5 (cdk5) activation requires interaction with three domains of p35. J Neurosci Res 2002;67:354-362.
28. 2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner. J Neurosci 2002;22:7879-7991.
29. Baouz S, Jacquet E, Accorsi K, et al: Sites of phosphorylation by protein kinase A in CDC25Mm/GRF1, a guanine nucleotide exchange factor for Ras. J Biol Chem 2001;276:1742-1729.
30. Kiyono M, Kato J, Kataoka T, Kaziro Y, Satoh T: Stimulation of Ras guanine nucleotide exchange activity of Ras-GRF1/CDC25(Mm) upon tyrosine phosphorylation by the Cdc42-regulated kinase ACK1. J Biol Chem 2000;275:29788-29793.
31. Kiyono M, Kaziro Y, Satoh T: Induction of rac-guanine nucleotide exchange activity of Ras-GRF1/CDC25(Mm) following phosphorylation by the nonreceptor tyrosine kinase Src. J Biol Chem 2000;275:5441-5446.
32. Yang H, Cooley D, Legakis JE, Ge Q, Andrade R, Mattingly RR: Phosphorylation of the Ras-GRF1 exchange factor at Ser916/898 reveals activation of Ras signaling in the cerebral cortex. J Biol Chem 2003;278:13278-13285.
33. Buchsbaum R, Telliez JB, Goonesekera S, Feig LA: The N-terminal pleckstrin, coiled-coil, and IQ domains of the exchange factor Ras-GRF act cooperatively to facilitate activation by calcium. Mol Cell Biol 1996;16:4888-4896.
34. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH: Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 1999;402:615-622.
35. Krapivinsky G, Krapivinsky L, Manasian Y, et al: The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. Neuron 2003;40:775-784.
36. Tian X, Gotoh T, Tsuji K, Lo EH, Huang S, Feig LA: Developmentally regulated role for Ras-GRFs in coupling NMDA glutamate receptors to Ras, Erk and CREB. EMBO J 2004;23:1567-1575.
37. Tian X, Feig LA: Basis for signaling specificity difference between Sos and Ras-GRF guanine nucleotide exchange factors. J Biol Chem 2001;276:47248-47256.
38. Li BS, Sun MK, Zhang L, et al: Regulation of NMDA receptors by cyclin-dependent kinase-5. Proc Natl Acad Sci USA 2001;98:12742-12747.
39. Font de Mora J, Esteban LM, Burks DJ, et al: Ras-GRF1 signaling is required for normal beta-cell development and glucose homeostasis. EMBO J 2003;22:3039-3049.
40. Ubeda M, Kemp DM, Habener JF: Glucose-induced expression of the cyclin-dependent protein kinase 5 activator p35 involved in Alzheimer's disease regulates insulin gene transcription in pancreatic beta-cells. Endocrinology 2004;145:3023-3031.
41. Giese KP, Friedman E, Telliez JB, et al: Hippocampus-dependent learning and memory is impaired in mice lacking the Ras-guanine-nucleotide releasing factor 1 (Ras-GRF1). Neuropharmacology 2001;41:791-800.
42. Brambilla R, Gnesutta N, Minichiello L, et al: A role for the Ras signalling pathway in synaptic transmission and long-term memory. Nature 1997;390:281-286.
43. Wei FY, Tomizawa K, Ohshima T, et al: Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability. J Neurochem 2005;93:502-512.
44. Cullen PJ, Lockyer PJ: Integration of calcium and Ras signalling. Nat Rev Mol Cell Biol 2002;3:339-48.
45. 2+ signals? Biochem Soc Trans 2003;31:966-969.
46. 2+. FEBS Lett 2003;546:6-10.
47. Shou C, Farnsworth CL, Neel BG, Feig LA: Molecular cloning of cDNAs encoding a guanine-nucleotide-releasing factor for Ras p21. Nature 1992;358:351-354.
48. Farnsworth CL, Freshney NW, Rosen LB, Ghosh A, Greenberg ME, Feig LA: Calcium activation of Ras mediated by neuronal exchange factor Ras-GRF. Nature 1995;376:524-527.
49. Martegani E, Vanoni M, Zippel R, et al: Cloning by functional complementation of a mouse cDNA encoding a homologue of CDC25, a Saccharomyces cerevisiae RAS activator. Embo J 1992;11:2151-2157.
50. Patrick GN, Zhou P, Kwon YT, Howley PM, Tsai LH: p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway. J Biol Chem 1998;273:24057-24064.